{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:07:07Z","timestamp":1769087227565,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00520-025-10298-y","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:48:36Z","timestamp":1767588516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of institutional guidelines for menstrual suppression and abnormal uterine bleeding in patients undergoing intensive chemotherapy for hematologic malignancies"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0830-0884","authenticated-orcid":false,"given":"Logan","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Stokvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Gojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Seraphin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"10","key":"10298_CR1","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","volume":"100","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Piccioli A et al (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100(10):3484\u20133488. https:\/\/doi.org\/10.1182\/blood-2002-01-0108","journal-title":"Blood"},{"key":"10298_CR2","doi-asserted-by":"publisher","unstructured":"National Comprehensive Cancer Network. Cancer-associated venous thromboembolic disease (Version 2.2024). https:\/\/doi.org\/10.6004\/jnccn.2024.0046","DOI":"10.6004\/jnccn.2024.0046"},{"key":"10298_CR3","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.165","author":"A Falanga","year":"2007","unstructured":"Falanga A, Rickles FR (2007) Management of thrombohemorrhagic syndromes (THS) in hematologic malignancies. Hematology Am Soc Hematol Educ Program. https:\/\/doi.org\/10.1182\/asheducation-2007.1.165","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"10298_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","volume":"74","author":"R Pihusch","year":"2002","unstructured":"Pihusch R, Salat C, Schmidt E et al (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74(9):1303\u20131309. https:\/\/doi.org\/10.1097\/00007890-200211150-00018","journal-title":"Transplantation"},{"issue":"12","key":"10298_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/sj.bmt.1705670","volume":"39","author":"M Franchini","year":"2007","unstructured":"Franchini M, Veneri D, Lippi G (2007) The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. Bone Marrow Transplant 39(12):729\u2013735. https:\/\/doi.org\/10.1038\/sj.bmt.1705670","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10298_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/s-0032-1331154","volume":"39","author":"M Franchini","year":"2013","unstructured":"Franchini M, Frattini F, Crestani S, Bonfanti C (2013) Bleeding complications in patients with hematologic malignancies. Semin Thromb Hemost 39(1):94\u2013100. https:\/\/doi.org\/10.1055\/s-0032-1331154","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10298_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejogrb.2007.03.012","volume":"134","author":"AM Quaas","year":"2007","unstructured":"Quaas AM, Ginsburg ES (2007) Prevention and treatment of uterine bleeding in hematologic malignancy. Eur J Obstet Gynecol Reprod Biol 134(1):3\u20138. https:\/\/doi.org\/10.1016\/j.ejogrb.2007.03.012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10298_CR8","unstructured":"(2021) Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment: ACOG Committee Opinion Summary, Number 817. Am J Obstet Gynecol 121(4):891\u2013896"},{"issue":"4","key":"10298_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/MOP.0000000000000359","volume":"28","author":"SM Quinn","year":"2016","unstructured":"Quinn SM, Louis-Jacques J (2016) Menstrual management and reproductive concerns in adolescent and young adult women with underlying hematologic or oncologic disease. Curr Opin Pediatr 28(4):421\u2013427. https:\/\/doi.org\/10.1097\/MOP.0000000000000359","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10298_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/AOG.0000000000001529","volume":"128","author":"DR Nebgen","year":"2016","unstructured":"Nebgen DR, Rhodes HE, Hartman C, Munsell MF, Lu KH (2016) Abnormal uterine bleeding as the presenting symptom of hematologic cancer. Obstet Gynecol 128(2):357\u2013363. https:\/\/doi.org\/10.1097\/AOG.0000000000001529","journal-title":"Obstet Gynecol"},{"key":"10298_CR11","doi-asserted-by":"publisher","unstructured":"(2019) Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG Committee Opinion, Number 785. Obstet Gynecol 134(3):e71-e83. https:\/\/doi.org\/10.1097\/AOG.0000000000003411","DOI":"10.1097\/AOG.0000000000003411"},{"key":"10298_CR12","doi-asserted-by":"publisher","unstructured":"(2013) ACOG committee opinion no. 557: management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol 121(4):891_896. https:\/\/doi.org\/10.1097\/01.AOG.0000428646.67925.9a","DOI":"10.1097\/01.AOG.0000428646.67925.9a"},{"key":"10298_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.thromres.2021.06.006","volume":"204","author":"MY Lim","year":"2021","unstructured":"Lim MY, Olson L, Rajpurkar MA, Weyand AC (2021) Concomitant use of combined hormonal contraceptives and antifibrinolytic agents for the management of heavy menstrual bleeding: a practice pattern survey. Thromb Res 204:95\u2013100. https:\/\/doi.org\/10.1016\/j.thromres.2021.06.006","journal-title":"Thromb Res"},{"issue":"5","key":"10298_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3109\/10428190109097723","volume":"42","author":"C Lhomm\u00e9","year":"2001","unstructured":"Lhomm\u00e9 C, Brault P, Bourhis JH et al (2001) Prevention of menstruation with leuprorelin (GnRH agonist) in women undergoing myelosuppressive chemotherapy or radiochemotherapy for hematological malignancies: a pilot study. Leuk Lymphoma 42(5):1033\u20131041. https:\/\/doi.org\/10.3109\/10428190109097723","journal-title":"Leuk Lymphoma"},{"issue":"17","key":"10298_CR15","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1200\/JCO.2000.18.17.3078","volume":"18","author":"BA Hutten","year":"2000","unstructured":"Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, B\u00fcller HR (2000) Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol 18(17):3078\u20133083. https:\/\/doi.org\/10.1200\/JCO.2000.18.17.3078","journal-title":"J Clin Oncol"},{"issue":"4","key":"10298_CR16","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.21873\/anticanres.11541","volume":"37","author":"PC Brady","year":"2017","unstructured":"Brady PC, Soiffer RJ, Ginsburg ES (2017) Continuation of a levonorgestrel intrauterine device during hematopoietic stem cell transplant: a case report. Anticancer Res 37(4):1985\u20131987. https:\/\/doi.org\/10.21873\/anticanres.11541","journal-title":"Anticancer Res"},{"issue":"2 Pt 2 Suppl 1","key":"10298_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/aog.0b013e318270ecd3","volume":"121","author":"SE Purisch","year":"2013","unstructured":"Purisch SE, Shanis D, Zerbe C, Merideth M, Cuellar-Rodriguez J, Stratton P (2013) Management of uterine bleeding during hematopoietic stem cell transplantation. Obstet Gynecol 121(2 Pt 2 Suppl 1):424\u2013427. https:\/\/doi.org\/10.1097\/aog.0b013e318270ecd3","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10298_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1182\/blood-2007-10-117051","volume":"112","author":"DE Gerber","year":"2008","unstructured":"Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB (2008) The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood 112(3):504\u2013510. https:\/\/doi.org\/10.1182\/blood-2007-10-117051","journal-title":"Blood"},{"issue":"3","key":"10298_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","volume":"65","author":"KM Curtis","year":"2016","unstructured":"Curtis KM, Tepper NK, Jatlaoui TC et al (2016) U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 65(3):1\u2013103. https:\/\/doi.org\/10.15585\/mmwr.rr6503a1","journal-title":"MMWR Recomm Rep"},{"key":"10298_CR20","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","volume":"91","author":"P Darney","year":"2009","unstructured":"Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM (2009) Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 91:1646\u20131653","journal-title":"Fertil Steril"},{"key":"10298_CR21","unstructured":"Red Cross national blood inventory plummets 25% in July -declares emergency blood shortage. https:\/\/www.redcross.org\/about-us\/news-and-events\/press-release\/2024\/red-cross-national-blood-inventory-plummets-in-july-declares-emergency-blood-shortage.html.\u00a0Accessed 29 Oct 2025\u00a0"},{"key":"10298_CR22","unstructured":"Importance of the blood supply. https:\/\/www.redcrossblood.org\/donate-blood\/how-to-donate\/how-blood-donations-help\/blood-needs-blood-supply.html.\u00a0Accessed 8 Aug 2024"},{"key":"10298_CR23","unstructured":"NCI dictionary of cancer terms: intensive chemotherapy. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/intensive-chemotherapy.\u00a0Accessed 6 Nov 2025"},{"issue":"19","key":"10298_CR24","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","volume":"368","author":"SJ Stanworth","year":"2013","unstructured":"Stanworth SJ, Estcourt LJ, Powter G et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368(19):1771\u20131780. https:\/\/doi.org\/10.1056\/NEJMoa1212772","journal-title":"N Engl J Med"},{"issue":"4","key":"10298_CR25","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/trf.12441","volume":"54","author":"LJ Estcourt","year":"2014","unstructured":"Estcourt LJ, Pinchon D, Symington E et al (2014) Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review. Transfusion 54(4):1166\u20131179. https:\/\/doi.org\/10.1111\/trf.12441","journal-title":"Transfusion"},{"key":"10298_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010982.pub2","author":"M Desborough","year":"2016","unstructured":"Desborough M, Estcourt LJ, Doree C et al (2016) Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010982.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10298-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-10298-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-10298-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:02:12Z","timestamp":1769025732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-10298-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10298"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-10298-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of The Johns Hopkins Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}